ANGPTL3 is involved in kidney injury in high-fat diet-fed mice by suppressing ACTN4 expression

Guanyu Li1, Di Lu1, Jingzhi Wang1

  • 1Nephrology Department, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, No. 318 Renmin Middle Road, Guangzhou City, 510623, China.

Lipids in Health and Disease
|September 19, 2022
PubMed
Abstract

Insights

Angiopoietin-like 3 (ANGPTL3) exacerbates kidney damage in hyperlipidemia. Removing ANGPTL3 in mice reduced lipid levels and improved podocyte injury, suggesting a therapeutic target.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Hyperlipidemia is a risk factor for chronic kidney disease.
  • Podocyte injury is a key feature of renal damage in hyperlipidemia.
  • The role of angiopoietin-like 3 (ANGPTL3) in hyperlipidemia-induced kidney injury is not fully understood.

Purpose of the Study:

  • To investigate the impact of ANGPTL3 on hyperlipidemia-induced renal injury.
  • To explore the potential mechanism involving alpha-actinin-4 (ACTN4) in this process.

Main Methods:

  • Utilized ANGPTL3 knockout and wild-type mice fed normal or high-fat diets.
  • Monitored serum lipids, urinary protein, and kidney pathology over 21 weeks.
  • Assessed glomerular expression of ANGPTL3, ACTN4, CD2AP, and podocin via immunohistochemistry.

Main Results:

  • High-fat diet induced hyperlipidemia and proteinuria in wild-type mice.
  • ANGPTL3 knockout mice showed reduced lipids, proteinuria, and improved podocyte foot process fusion.
  • ANGPTL3 expression increased with high-fat diet, while ACTN4 expression decreased, an effect mitigated in knockout mice.

Conclusions:

  • ANGPTL3 contributes to hyperlipidemia-associated podocyte injury.
  • The mechanism may involve alterations in ACTN4 expression.
  • Targeting ANGPTL3 could be a strategy for managing hyperlipidemia-related kidney disease.